100
Views
0
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Molecular crystals and computational exploration of imines as drugs with reference to SARS-CoV-2 viral proteins

& ORCID Icon
 

Abstract

Three Imines (H2L1-H2L3) were designed, synthesized, and examined the molecular docking with SARS-CoV-2 Mpro (PDB ID: 6LU7 & 7LKD). The molecular docking results reveals that the imines (H2L1-H2L3) with 6LU7 protein of SARS-CoV-2 virus exhibited the binding affinity (ΔG) of −6.0, −6.4, and −6.8 kcal/mol with good inhibition constant (Ki) of 4.113, 4.237, and 4.239 µM, respectively. The docking results of the imines (H2L1-H2L3) with 7LKD also resulted binding affinity (ΔG) of −7.3, −7.8, and −7.5 kcal/mol with good inhibition constant (Ki) of 4.459, 4.897, and 5.638 µM, respectively. The molecular docking analysis predicted that the imines (H2L1-H2L3) may be used as anti-SARS-CoV-2 virus.

Acknowledgments

The author is thankful to the Sophisticated Analytical Instrument Facility (SAIF), IIT Madras, India for single crystal data collection of the imines (H2L1-H2L3). We must acknowledge to SAIF, IIT Patna, India for NMR spectral analysis. For computer time, this research used the resources of the computational facility at Department of Chemistry, NIT Patna, India.

Authors’ contributions

Simranjeet Singh ([email protected]): Formal analysis, Investigation, writing original draft. Mukesh Choudhary ([email protected]): Supervision, Conceptualization, Methodology, Visualization, Resources.

Supporting information

Full spectral data, computational details, molecular docking results, and biological outputs are given in the supporting information.

Disclosure statement

The authors declare no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.